A Systematic Review on Healthcare Artificial Intelligent Conversational Agents for Chronic Conditions

Detecting Artificial Intelligence-Generated Versus Human-Written Medical Student Essays: Semirandomized Controlled Study

BACKGROUND

Large language models, exemplified by ChatGPT, have reached a level of sophistication that makes distinguishing between human- and artificial intelligence (AI)-generated texts increasingly challenging. This has raised concerns in academia, particularly in medicine, where the accuracy and authenticity of written work are paramount.

OBJECTIVE

This semirandomized controlled study aims to examine the ability of 2 blinded expert groups with different levels of content familiarity-medical professionals and humanities scholars with expertise in textual analysis-to distinguish between longer scientific texts in German written by medical students and those generated by ChatGPT. Additionally, the study sought to analyze the reasoning behind their identification choices, particularly the role of content familiarity and linguistic features.

METHODS

Between May and August 2023, a total of 35 experts (medical: n=22; humanities: n=13) were each presented with 2 pairs of texts on different medical topics. Each pair had similar content and structure: 1 text was written by a medical student, and the other was generated by ChatGPT (version 3.5, March 2023). Experts were asked to identify the AI-generated text and justify their choice. These justifications were analyzed through a multistage, interdisciplinary qualitative analysis to identify relevant textual features. Before unblinding, experts rated each text on 6 characteristics: linguistic fluency and spelling/grammatical accuracy, scientific quality, logical coherence, expression of knowledge limitations, formulation of future research questions, and citation quality. Univariate tests and multivariate logistic regression analyses were used to examine associations between participants' characteristics, their stated reasons for author identification, and the likelihood of correctly determining a text's authorship.

RESULTS

Overall, in 48 out of 69 (70%) decision rounds, participants accurately identified the AI-generated texts, with minimal difference between groups (medical: 31/43, 72%; humanities: 17/26, 65%; odds ratio [OR] 1.37, 95% CI 0.5-3.9). While content errors had little impact on identification accuracy, stylistic features-particularly redundancy (OR 6.90, 95% CI 1.01-47.1), repetition (OR 8.05, 95% CI 1.25-51.7), and thread/coherence (OR 6.62, 95% CI 1.25-35.2)-played a crucial role in participants' decisions to identify a text as AI-generated.

CONCLUSIONS

The findings suggest that both medical and humanities experts were able to identify ChatGPT-generated texts in medical contexts, with their decisions largely based on linguistic attributes. The accuracy of identification appears to be independent of experts' familiarity with the text content. As the decision-making process primarily relies on linguistic attributes-such as stylistic features and text coherence-further quasi-experimental studies using texts from other academic disciplines should be conducted to determine whether instructions based on these features can enhance lecturers' ability to distinguish between student-authored and AI-generated work.

Conversational agents in physical and psychological symptom management: A systematic review of randomized controlled trials

BACKGROUND

Effective management of physical and psychological symptoms is a critical component of comprehensive care for both chronic disease patients and apparently healthy individuals experiencing episodic symptoms. Conversational agents, which are dialog systems capable of understanding and generating human language, have emerged as a potential tool to enhance symptom management through interactive support.

OBJECTIVE

To examine the characteristics and effectiveness of conversational agent-delivered interventions reported in randomized controlled trials (RCTs) in the management of both physical and psychological symptoms.

DESIGN

A systematic review.

METHODS

A comprehensive search was performed in Pubmed, ACM Digital Library, CINAHL, EMBASE, PyscInfo, Web of Science, Scopus and gray literature sources from their inception to Oct 2024. Search terms included "conversational agent", "symptom", "randomized controlled trial" and their synonyms and hyponyms. Duplicates were identified by EndNote, and titles, abstracts and full texts were independently screened according to predefined criteria. Data extraction focused on basic study characteristics and conversational agent details, with The Cochrane Risk of Bias 2.0 tool employed for bias assessment.

RESULTS

The search yielded 2756 articles and 29 were finally included for review. The included studies predominantly came from developed countries (n = 23) and were conducted between 2020 and 2024 (n = 24). The studies frequently evaluated the feasibility and acceptability of conversational agent interventions (n = 14), with a predominantly focus on psychological symptoms (depression, anxiety, etc.) (n = 17). A few studies focused on physical symptoms (pain, etc.) (n = 4), while others addressed both symptoms (n = 8). Twenty-five distinct conversational agents (Woebot, Tess, etc.) were evaluated, utilizing platforms ranging from proprietary applications to common messaging channels like WeChat and Facebook Messenger. Cognitive Behavioral Therapy (CBT) was a commonly integrated approach (n = 22), with rule-based dialogs (n = 22) as the most commonly dialog system methods and Natural Language Processing (NLP) (n = 15) as the predominant AI techniques. The median recruitment and completion rates were 72 % and 79 %, respectively. The majority of studies reported positive user experiences and significant symptom management improvements (n = 22). However, risk of bias was high in seventeen studies and presented some concerns in nine others.

CONCLUSIONS

Conversational agents have shown promise in enhancing both physical and psychological symptom management through positive user experiences and effectiveness. However, the high risk of bias identified in many studies warrants caution in interpreting these findings. Future research should prioritize the methodological quality of RCTs to strengthen the evidence base supporting the use of conversational agents as a complementary tool in symptom management.

Exploring the Role of Voice Assistants in Managing Noncommunicable Diseases: A Systematic Review on Clinical, Behavioral Outcomes, Quality of Life, and User Experiences

BACKGROUND

Non-communicable diseases (NCDs) represent a leading cause of global mortality, demanding innovative approaches to management. Voice assistants (VAs) have emerged as promising tools in healthcare, offering support for self-management, behavioral engagement, and patient care. This systematic review evaluates the role of VAs in NCD management, analyzing their impact on clinical and behavioral outcomes, quality of life, usability, and user experiences while identifying barriers to their adoption.

METHODS

A systematic search was conducted in PubMed, Scopus, and Web of Science from January 2014 to October 2024. Studies were selected based on predefined inclusion and exclusion criteria using the PRISMA guidelines. Data extraction focused on outcomes such as usability, acceptability, adherence, clinical metrics, and quality of life. The risk of bias was assessed using the Cochrane Risk of Bias (RoB) 2 and ROBINS-I tools.

RESULTS

Eight studies involving 541 participants were included, examining VAs across various NCD contexts such as diabetes, cardiovascular diseases, and mental health. While VAs demonstrated good usability and moderate adherence, their clinical and quality-of-life outcomes were modest. Behavioral improvements, such as increased physical activity and problem-solving skills, were noted in some interventions. Key challenges included privacy concerns, speech recognition errors, and accessibility issues.

CONCLUSIONS

VAs show potential as supportive tools in NCD management, especially for enhancing patient engagement and self-management, and their impact on clinical outcomes and long-term usability requires further investigation. Future research should focus on diverse populations, standardized metrics, and comparative studies with alternative technologies.

Identification of Use Cases, Target Groups, and Motivations Around Adopting Smart Speakers for Health Care and Social Care Settings: Scoping Review

BACKGROUND

Conversational agents (CAs) are finding increasing application in health and social care, not least due to their growing use in the home. Recent developments in artificial intelligence, machine learning, and natural language processing have enabled a variety of new uses for CAs. One type of CA that has received increasing attention recently is smart speakers.

OBJECTIVE

The aim of our study was to identify the use cases, user groups, and settings of smart speakers in health and social care. We also wanted to identify the key motivations for developers and designers to use this particular type of technology.

METHODS

We conducted a scoping review to provide an overview of the literature on smart speakers in health and social care. The literature search was conducted between February 2023 and March 2023 and included 3 databases (PubMed, Scopus, and Sociological Abstracts), supplemented by Google Scholar. Several keywords were used, including technology (eg, voice assistant), product name (eg, Amazon Alexa), and setting (health care or social care). Publications were included if they met the predefined inclusion criteria: (1) published after 2015 and (2) used a smart speaker in a health care or social care setting. Publications were excluded if they met one of the following criteria: (1) did not report on the specific devices used, (2) did not focus specifically on smart speakers, (3) were systematic reviews and other forms of literature-based publications, and (4) were not published in English. Two reviewers collected, reviewed, abstracted, and analyzed the data using qualitative content analysis.

RESULTS

A total of 27 articles were included in the final review. These articles covered a wide range of use cases in different settings, such as private homes, hospitals, long-term care facilities, and outpatient services. The main target group was patients, especially older users, followed by doctors and other medical staff members.

CONCLUSIONS

The results show that smart speakers have diverse applications in health and social care, addressing different contexts and audiences. Their affordability and easy-to-use interfaces make them attractive to various stakeholders. It seems likely that, due to technical advances in artificial intelligence and the market power of the companies behind the devices, there will be more use cases for smart speakers in the near future.

Feasibility and Preliminary Behavioral and Clinical Efficacy of a Diabetes Education Chatbot Pilot Among Adults With Type 2 Diabetes

BACKGROUND

Diabetes self-management education and support (DSMES) improves diabetes outcomes yet remains consistently underutilized. Chatbot technology offers the potential to increase access to and engagement in DSMES. Evidence supporting the case for chatbot uptake and efficacy in people with diabetes (PWD) is needed.

METHOD

A diabetes education and support chatbot was deployed in a regional health care system. Adults with type 2 diabetes with an A1C of 8.0% to 8.9% and/or having recently completed a 12-week diabetes care management program were enrolled in a pilot program. Weekly chats included three elements: knowledge assessment, limited self-reporting of blood glucose data and medication taking behaviors, and education content (short videos and printable materials). A clinician facing dashboard identified need for escalation via flags based on participant responses. Data were collected to assess satisfaction, engagement, and preliminary glycemic outcomes.

RESULTS

Over 16 months, 150 PWD (majority above 50 years of age, female, and African American) were enrolled. The unenrollment rate was 5%. Most escalation flags (N = 128) were for hypoglycemia (41%), hyperglycemia (32%), and medication issues (11%). Overall satisfaction was high for chat content, length, and frequency, and 87% reported increased self-care confidence. Enrollees completing more than one chat had a mean drop in A1C of -1.04%, whereas those completing one chat or less had a mean increase in A1C of +0.09% (P = .008).

CONCLUSION

This diabetes education chatbot pilot demonstrated PWD acceptability, satisfaction, and engagement plus preliminary evidence of self-care confidence and A1C improvement. Further efforts are needed to validate these promising early findings.

Transforming healthcare with chatbots: Uses and applications-A scoping review

Purpose

The COVID-19 pandemic has intensified the demand and use of healthcare resources, prompting the search for efficient solutions under budgetary constraints. In this context, the increasing use of artificial intelligence and telemedicine has emerged as a key strategy to optimize healthcare delivery and resources. Consequently, chatbots have emerged as innovative tools in various healthcare fields, such as mental health and patient monitoring, offering therapeutic conversations and early interventions. This systematic review aims to explore the current state of chatbots in the healthcare sector, meticulously evaluating their effectiveness, practical applications, and potential benefits.

Methods

This systematic review was conducted following PRISMA guidelines, utilizing three databases, including PubMed, Web of Science, and Scopus, to identify relevant studies on the use and cost of chatbots in health over the past 5 years.

Results

Several articles were identified through the database search (n = 31). The chatbot interventions were categorized by similar types. The reviewed articles highlight the diverse applications of chatbot interventions in healthcare, including mental health support, medical information, appointment management, health education, lifestyle changes, and COVID-19 management, demonstrating significant potential across these areas.

Conclusion

Furthermore, there are challenges regarding the implementation of chatbots, compatibility with other systems, and ethical considerations that may arise in different healthcare settings. Addressing these issues will be essential to maximize the benefits of chatbots, mitigate risks, and ensure equitable access to these health innovations.

Talking technology: exploring chatbots as a tool for cataract patient education

CLINICAL RELEVANCE

Worldwide, millions suffer from cataracts, which impair vision and quality of life. Cataract education improves outcomes, satisfaction, and treatment adherence. Lack of health literacy, language and cultural barriers, personal preferences, and limited resources may all impede effective communication.

BACKGROUND

AI can improve patient education by providing personalised, interactive, and accessible information tailored to patient understanding, interest, and motivation. AI chatbots can have human-like conversations and give advice on numerous topics.

METHODS

This study investigated the efficacy of chatbots in cataract patient education relative to traditional resources like the AAO website, focusing on information accuracy,understandability, actionability, and readability. A descriptive comparative design was used to analyse quantitative data from frequently asked questions about cataracts answered by ChatGPT, Bard, Bing AI, and the AAO website. SOLO taxonomy, PEMAT, and the Flesch-Kincaid ease score were used to collect and analyse the data.

RESULTS

Chatbots scored higher than AAO website on cataract-related questions in terms of accuracy (mean SOLO score ChatGPT: 3.1 ± 0.31, Bard: 2.9 ± 0.72, Bing AI: 2.65 ± 0.49, AAO website: 2.4 ± 0.6, (p < 0.001)). For understandability (mean PEMAT-U score AAO website: 0,89 ± 0,04, ChatGPT 0,84 ± 0,02, Bard: 0,84 ± 0,02, Bing AI: 0,81 ± 0,02, (p < 0.001)), and actionability (mean PEMAT-A score ChatGPT: 0.86 ± 0.03, Bard: 0.85 ± 0.06, Bing AI: 0.81 ± 0.05, AAO website: 0.81 ± 0.06, (p < 0.001)) AAO website scored better than chatbots. Flesch-Kincaid readability ease analysis showed that Bard (55,5 ± 8,48) had the highest mean score, followed by AAO website (51,96 ± 12,46), Bing AI (41,77 ± 9,53), and ChatGPT (34,38 ± 9,75, (p < 0.001)).

CONCLUSION

Chatbots have the potential to provide more detailed and accurate data than the AAO website. On the other hand, the AAO website has the advantage of providing information that is more understandable and practical. When patient preferences are not taken into account, generalised or biased information can decrease reliability.

Digital Health Divide: Opportunities for Reducing Health Disparities and Promoting Equitable Care for Maternal and Child Health Populations

The integration of telehealth into maternal and child health (MCH) care presents an opportunity to enhance health equity, offering solutions to bridge gaps in access and quality of care. This paper explores the impact and reach of telehealth services on MCH, emphasizing its potential to address disparities in healthcare access, particularly for underserved and marginalized populations. Telehealth facilitates improved access to care by reducing geographical barriers, offering convenient and flexible consultation options, and providing cost-effective solutions for low-income families. This paper also crystallizes the importance of telehealth services on the continuity of care through consistent remote monitoring, which is crucial for managing chronic conditions and ensuring timely interventions during pregnancy and early childhood. However, the effective implementation of telehealth in MCH also faces significant challenges, including the digital divide, which limits technology access and digital literacy among vulnerable populations. Enhancing digital literacy is essential for empowering individuals to navigate telehealth services effectively and to make informed health decisions. To advance health equity, it is crucial to address these challenges by expanding technology access, improving digital literacy, and developing supportive policies that ensure comprehensive telehealth coverage while considering the Social Determinants of Health (SDoH). This paper explores the importance of leveraging telehealth and other timely interventions to improve MCH equity and justice, including the provision of technological resources and comprehensive policy frameworks. By addressing these factors, telehealth can significantly contribute to reducing health disparities and promoting equitable care for all maternal and child populations.

A systematic review of artificial intelligence-powered (AI-powered) chatbot intervention for managing chronic illness

BACKGROUND

Utilizing artificial intelligence (AI) in chatbots, especially for chronic diseases, has become increasingly prevalent. These AI-powered chatbots serve as crucial tools for enhancing patient communication, addressing the rising prevalence of chronic conditions, and meeting the growing demand for supportive healthcare applications. However, there is a notable gap in comprehensive reviews evaluating the impact of AI-powered chatbot interventions in healthcare within academic literature. This study aimed to assess user satisfaction, intervention efficacy, and the specific characteristics and AI architectures of chatbot systems designed for chronic diseases.

METHOD

A thorough exploration of the existing literature was undertaken by employing diverse databases such as PubMed MEDLINE, CINAHL, EMBASE, PsycINFO, ACM Digital Library and Scopus. The studies incorporated in this analysis encompassed primary research that employed chatbots or other forms of AI architecture in the context of preventing, treating or rehabilitating chronic diseases. The assessment of bias risk was conducted using Risk of 2.0 Tools.

RESULTS

Seven hundred and eighty-four results were obtained, and subsequently, eight studies were found to align with the inclusion criteria. The intervention methods encompassed health education (n = 3), behaviour change theory (n = 1), stress and coping (n = 1), cognitive behavioural therapy (n = 2) and self-care behaviour (n = 1). The research provided valuable insights into the effectiveness and user-friendliness of AI-powered chatbots in handling various chronic conditions. Overall, users showed favourable acceptance of these chatbots for self-managing chronic illnesses.

CONCLUSIONS

The reviewed studies suggest promising acceptance of AI-powered chatbots for self-managing chronic conditions. However, limited evidence on their efficacy due to insufficient technical documentation calls for future studies to provide detailed descriptions and prioritize patient safety. These chatbots employ natural language processing and multimodal interaction. Subsequent research should focus on evidence-based evaluations, facilitating comparisons across diverse chronic health conditions.

Chatbots in medicine: certification process and applied use case

Chatbots are computer programs designed to engage in natural language conversations in an easy and understandable way. Their use has been accelerated recently with the advent of large language models. However, their application in medicine and healthcare has been limited due to concerns over data privacy, the risk of providing medical diagnoses, and ensuring regulatory and legal compliance. Medicine and healthcare could benefit from chatbots if their scope is carefully defined and if they are used appropriately and monitored long-term. The confIAnce chatbot, developed at the Geneva University Hospitals and the University of Geneva, is an informational tool aimed at providing simplified information to the general public about primary care and chronic diseases. In this paper, we describe the certification and regulatory aspects applicable to chatbots in healthcare, particularly in primary care medicine. We use the confIAnce chatbot as a case study to explore the definition and classification of a medical device and its application to chatbots, considering the applicable Swiss regulations and the European Union AI Act. Chatbots can be classified anywhere from non-medical devices (informational tools that do not handle patient data or provide recommendations for treatment or diagnosis) to Class III medical devices (high-risk tools capable of predicting potentially fatal events and enabling a pre-emptive medical intervention). Key considerations in the definition and certification process include defining the chatbot's scope, ensuring compliance with regulations, maintaining security and safety, and continuously evaluating performance, risks, and utility. A lexicon of relevant terms related to artificial intelligence in healthcare, medical devices, and regulatory frameworks is also presented in this paper. Chatbots hold potential for both patients and healthcare professionals, provided that their scope of practice is clearly defined, and that they comply with regulatory requirements. This review aims to provide transparency by outlining the steps required for certification and regulatory compliance, making it valuable for healthcare professionals, scientists, developers, and patients.

Roles, Users, Benefits, and Limitations of Chatbots in Health Care: Rapid Review

BACKGROUND

Chatbots, or conversational agents, have emerged as significant tools in health care, driven by advancements in artificial intelligence and digital technology. These programs are designed to simulate human conversations, addressing various health care needs. However, no comprehensive synthesis of health care chatbots' roles, users, benefits, and limitations is available to inform future research and application in the field.

OBJECTIVE

This review aims to describe health care chatbots' characteristics, focusing on their diverse roles in the health care pathway, user groups, benefits, and limitations.

METHODS

A rapid review of published literature from 2017 to 2023 was performed with a search strategy developed in collaboration with a health sciences librarian and implemented in the MEDLINE and Embase databases. Primary research studies reporting on chatbot roles or benefits in health care were included. Two reviewers dual-screened the search results. Extracted data on chatbot roles, users, benefits, and limitations were subjected to content analysis.

RESULTS

The review categorized chatbot roles into 2 themes: delivery of remote health services, including patient support, care management, education, skills building, and health behavior promotion, and provision of administrative assistance to health care providers. User groups spanned across patients with chronic conditions as well as patients with cancer; individuals focused on lifestyle improvements; and various demographic groups such as women, families, and older adults. Professionals and students in health care also emerged as significant users, alongside groups seeking mental health support, behavioral change, and educational enhancement. The benefits of health care chatbots were also classified into 2 themes: improvement of health care quality and efficiency and cost-effectiveness in health care delivery. The identified limitations encompassed ethical challenges, medicolegal and safety concerns, technical difficulties, user experience issues, and societal and economic impacts.

CONCLUSIONS

Health care chatbots offer a wide spectrum of applications, potentially impacting various aspects of health care. While they are promising tools for improving health care efficiency and quality, their integration into the health care system must be approached with consideration of their limitations to ensure optimal, safe, and equitable use.

Evaluating the Potential and Pitfalls of AI-Powered Conversational Agents as Humanlike Virtual Health Carers in the Remote Management of Noncommunicable Diseases: Scoping Review

BACKGROUND

The rising prevalence of noncommunicable diseases (NCDs) worldwide and the high recent mortality rates (74.4%) associated with them, especially in low- and middle-income countries, is causing a substantial global burden of disease, necessitating innovative and sustainable long-term care solutions.

OBJECTIVE

This scoping review aims to investigate the impact of artificial intelligence (AI)-based conversational agents (CAs)-including chatbots, voicebots, and anthropomorphic digital avatars-as human-like health caregivers in the remote management of NCDs as well as identify critical areas for future research and provide insights into how these technologies might be used effectively in health care to personalize NCD management strategies.

METHODS

A broad literature search was conducted in July 2023 in 6 electronic databases-Ovid MEDLINE, Embase, PsycINFO, PubMed, CINAHL, and Web of Science-using the search terms "conversational agents," "artificial intelligence," and "noncommunicable diseases," including their associated synonyms. We also manually searched gray literature using sources such as ProQuest Central, ResearchGate, ACM Digital Library, and Google Scholar. We included empirical studies published in English from January 2010 to July 2023 focusing solely on health care-oriented applications of CAs used for remote management of NCDs. The narrative synthesis approach was used to collate and summarize the relevant information extracted from the included studies.

RESULTS

The literature search yielded a total of 43 studies that matched the inclusion criteria. Our review unveiled four significant findings: (1) higher user acceptance and compliance with anthropomorphic and avatar-based CAs for remote care; (2) an existing gap in the development of personalized, empathetic, and contextually aware CAs for effective emotional and social interaction with users, along with limited consideration of ethical concerns such as data privacy and patient safety; (3) inadequate evidence of the efficacy of CAs in NCD self-management despite a moderate to high level of optimism among health care professionals regarding CAs' potential in remote health care; and (4) CAs primarily being used for supporting nonpharmacological interventions such as behavioral or lifestyle modifications and patient education for the self-management of NCDs.

CONCLUSIONS

This review makes a unique contribution to the field by not only providing a quantifiable impact analysis but also identifying the areas requiring imminent scholarly attention for the ethical, empathetic, and efficacious implementation of AI in NCD care. This serves as an academic cornerstone for future research in AI-assisted health care for NCD management.

TRIAL REGISTRATION

Open Science Framework; https://doi.org/10.17605/OSF.IO/GU5PX.

Assessing digital health knowledge, attitudes and practices among nurses in Naples: a survey study protocol

INTRODUCTION

Digital competencies are essential for nurses to actively participate in the digitisation of healthcare systems. Therefore, it is important to assess their skill levels to identify strengths and areas for improvement.

METHOD AND ANALYSIS

This study aims to investigate nurses' knowledge, attitudes, behaviours, subjective norms and behavioural control regarding digital health. A knowledge-attitude-practice model guided the development of a structured questionnaire divided into six sections. A sample of 480 registered nurses of Naples will be involved in the study. After conducting a pretest, an invitation will be publicised through the institutional communication channels of Nurses Provincial Order of Naples. Nurses will respond via a unique link or quick response code sent through a PEC email system (a legally valid email system, which guarantees delivery and receipt). They will have 30 days to complete the survey, scheduled between May and July 2024.

ETHICS AND DISSEMINATION

No ethics committee approval was required, as the study does not involve minors, direct or indirect physical or physiological harm to participants, or clinical trials. Anonymity will be guaranteed at all data collection and processing levels. The results will be broadly distributed through conference presentations and peer-reviewed publications. The effective use of digital technologies by healthcare professionals can bring significant improvements to healthcare services and help improve the health of individuals and community health. The study's findings will serve as a foundation for developing and implementing educational programmes related to eHealth and telemedicine, promoting the harmonisation of such programmes.

Telephone follow-up based on artificial intelligence technology among hypertension patients: Reliability study

Artificial intelligence (AI) telephone is reliable for the follow-up and management of hypertensives. It takes less time and is equivalent to manual follow-up to a high degree. We conducted a reliability study to evaluate the efficiency of AI telephone follow-up in the management of hypertension. During May 18 and June 30, 2020, 350 hypertensives managed by the Pengpu Community Health Service Center in Shanghai were recruited for follow-up, once by AI and once by a human. The second follow-up was conducted within 3-7 days (mean 5.5 days). The mean length time of two calls were compared by paired t-test, and Cohen's Kappa coefficient was used to evaluate the reliability of the results between the two follow-up visits. The mean length time of AI calls was shorter (4.15 min) than that of manual calls (5.24 min, P < .001). The answers related to the symptoms showed moderate to substantial consistency (κ:.465-.624, P < .001), and those related to the complications showed fair consistency (κ:.349, P < .001). In terms of lifestyle, the answer related to smoking showed a very high consistency (κ:.915, P < .001), while those addressing salt consumption, alcohol consumption, and exercise showed moderate to substantial consistency (κ:.402-.645, P < .001). There was moderate consistency in regular usage of medication (κ:.484, P < .001).

The next generation of healthcare ecosystem in the metaverse

The Metaverse has gained wide attention for being the application interface for the next generation of Internet. The potential of the Metaverse is growing, as Web 3·0 development and adoption continues to advance medicine and healthcare. We define the next generation of interoperable healthcare ecosystem in the Metaverse. We examine the existing literature regarding the Metaverse, explain the technology framework to deliver an immersive experience, along with a technical comparison of legacy and novel Metaverse platforms that are publicly released and in active use. The potential applications of different features of the Metaverse, including avatar-based meetings, immersive simulations, and social interactions are examined with different roles from patients to healthcare providers and healthcare organizations. Present challenges in the development of the Metaverse healthcare ecosystem are discussed, along with potential solutions including capabilities requiring technological innovation, use cases requiring regulatory supervision, and sound governance. This proposed concept and framework of the Metaverse could potentially redefine the traditional healthcare system and enhance digital transformation in healthcare. Similar to AI technology at the beginning of this decade, real-world development and implementation of these capabilities are relatively nascent. Further pragmatic research is needed for the development of an interoperable healthcare ecosystem in the Metaverse.

A scoping review of methodologies for applying artificial intelligence to physical activity interventions

PURPOSE

This scoping review aimed to offer researchers and practitioners an understanding of artificial intelligence (AI) applications in physical activity (PA) interventions; introduce them to prevalent machine learning (ML), deep learning (DL), and reinforcement learning (RL) algorithms; and encourage the adoption of AI methodologies.

METHODS

A scoping review was performed in PubMed, Web of Science, Cochrane Library, and EBSCO focusing on AI applications for promoting PA or predicting related behavioral or health outcomes. AI methodologies were summarized and categorized to identify synergies, patterns, and trends informing future research. Additionally, a concise primer on predominant AI methodologies within the realm of PA was provided to bolster understanding and broader application.

RESULTS

The review included 24 studies that met the predetermined eligibility criteria. AI models were found effective in detecting significant patterns of PA behavior and associations between specific factors and intervention outcomes. Most studies comparing AI models to traditional statistical approaches reported higher prediction accuracy for AI models on test data. Comparisons of different AI models yielded mixed results, likely due to model performance being highly dependent on the dataset and task. An increasing trend of adopting state-of-the-art DL and RL models over standard ML was observed, addressing complex human-machine communication, behavior modification, and decision-making tasks. Six key areas for future AI adoption in PA interventions emerged: personalized PA interventions, real-time monitoring and adaptation, integration of multimodal data sources, evaluation of intervention effectiveness, expanding access to PA interventions, and predicting and preventing injuries.

CONCLUSION

The scoping review highlights the potential of AI methodologies for advancing PA interventions. As the field progresses, staying informed and exploring emerging AI-driven strategies is essential for achieving significant improvements in PA interventions and fostering overall well-being.

Redefining Virtual Assistants in Health Care: The Future With Large Language Models

This editorial explores the evolving and transformative role of large language models (LLMs) in enhancing the capabilities of virtual assistants (VAs) in the health care domain, highlighting recent research on the performance of VAs and LLMs in health care information sharing. Focusing on recent research, this editorial unveils the marked improvement in the accuracy and clinical relevance of responses from LLMs, such as GPT-4, compared to current VAs, especially in addressing complex health care inquiries, like those related to postpartum depression. The improved accuracy and clinical relevance with LLMs mark a paradigm shift in digital health tools and VAs. Furthermore, such LLM applications have the potential to dynamically adapt and be integrated into existing VA platforms, offering cost-effective, scalable, and inclusive solutions. These suggest a significant increase in the applicable range of VA applications, as well as the increased value, risk, and impact in health care, moving toward more personalized digital health ecosystems. However, alongside these advancements, it is necessary to develop and adhere to ethical guidelines, regulatory frameworks, governance principles, and privacy and safety measures. We need a robust interdisciplinary collaboration to navigate the complexities of safely and effectively integrating LLMs into health care applications, ensuring that these emerging technologies align with the diverse needs and ethical considerations of the health care domain.

Exploring the characteristics of conversational agents in chronic disease management interventions: A scoping review

Objective

With the increasing global burden of chronic diseases, there is the potential for conversational agents (CAs) to assist people in actively managing their conditions. This paper reviews different types of CAs used for chronic condition management, delving into their characteristics and the chosen study designs. This paper also discusses the potential of these CAs to enhance the health and well-being of people with chronic conditions.

Methods

A search was performed in February 2023 on PubMed, ACM Digital Library, Scopus, and IEEE Xplore. Studies were included if they focused on chronic disease management or prevention and if systems were evaluated on target user groups.

Results

The 42 selected studies explored diverse types of CAs across 11 health conditions. Personalization varied, with 25 CAs not adapting message content, while others incorporated user characteristics and real-time context. Only 12 studies used medical records in conjunction with CAs for conditions like diabetes, mental health, cardiovascular issues, and cancer. Despite measurement method variations, the studies predominantly emphasized improved health outcomes and positive user attitudes toward CAs.

Conclusions

The results underscore the need for CAs to adapt to evolving patient needs, customize interventions, and incorporate human support and medical records for more effective care. It also highlights the potential of CAs to play a more active role in helping individuals manage their conditions and notes the value of linguistic data generated during user interactions. The analysis acknowledges its limitations and encourages further research into the use and potential of CAs in disease-specific contexts.

Patient Acceptability of Symptom Screening and Patient Education Using a Chatbot for Autoimmune Inflammatory Diseases: Survey Study

BACKGROUND

Chatbots have the potential to enhance health care interaction, satisfaction, and service delivery. However, data regarding their acceptance across diverse patient populations are limited. In-depth studies on the reception of chatbots by patients with chronic autoimmune inflammatory diseases are lacking, although such studies are vital for facilitating the effective integration of chatbots in rheumatology care.

OBJECTIVE

We aim to assess patient perceptions and acceptance of a chatbot designed for autoimmune inflammatory rheumatic diseases (AIIRDs).

METHODS

We administered a comprehensive survey in an outpatient setting at a top-tier rheumatology referral center. The target cohort included patients who interacted with a chatbot explicitly tailored to facilitate diagnosis and obtain information on AIIRDs. Following the RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance) framework, the survey was designed to gauge the effectiveness, user acceptability, and implementation of the chatbot.

RESULTS

Between June and October 2022, we received survey responses from 200 patients, with an equal number of 100 initial consultations and 100 follow-up (FU) visits. The mean scores on a 5-point acceptability scale ranged from 4.01 (SD 0.63) to 4.41 (SD 0.54), indicating consistently high ratings across the different aspects of chatbot performance. Multivariate regression analysis indicated that having a FU visit was significantly associated with a greater willingness to reuse the chatbot for symptom determination (P=.01). Further, patients' comfort with chatbot diagnosis increased significantly after meeting physicians (P<.001). We observed no significant differences in chatbot acceptance according to sex, education level, or diagnosis category.

CONCLUSIONS

This study underscores that chatbots tailored to AIIRDs have a favorable reception. The inclination of FU patients to engage with the chatbot signifies the possible influence of past clinical encounters and physician affirmation on its use. Although further exploration is required to refine their integration, the prevalent positive perceptions suggest that chatbots have the potential to strengthen the bridge between patients and health care providers, thus enhancing the delivery of rheumatology care to various cohorts.

Adaptation of the Gabby conversational agent system to improve the sexual and reproductive health of young women in Lesotho

Introduction

Young women from the low-middle-income country of Lesotho in southern Africa frequently report limited knowledge regarding sexual and reproductive health issues and engage in risky sexual behaviors. The purpose of this study is to describe the adaptation of an evidence-based conversational agent system for implementation in Lesotho and provide qualitative data pertaining to the success of the said adaptation.

Methods

An embodied conversational agent system used to provide preconception health advice in the United States was clinically and culturally adapted for use in the rural country of Lesotho in southern Africa. Inputs from potential end users, health leaders, and district nurses guided the adaptations. Focus group discussions with young women aged 18-28 years who had used the newly adapted system renamed "Nthabi" for 3-4 weeks and key informant interviews with Ministry of Health leadership were conducted to explore their views of the acceptability of the said adaptation. Data were analyzed using NVivo software, and a thematic content analysis approach was employed in the study.

Results

A total of 33 women aged 18-28 years used Nthabi for 3-4 weeks; eight (24.2%) of them were able to download and use the app on their mobile phones and 25 (75.8%) of them used the app on a tablet provided to them. Focus group participants (n = 33) reported that adaptations were culturally appropriate and provided relevant clinical information. The participants emphasized that the physical characteristics, personal and non-verbal behaviors, utilization of Sesotho words and idioms, and sensitively delivered clinical content were culturally appropriate for Lesotho. The key informants from the Ministry leadership (n = 10) agreed that the adaptation was successful, and that the system holds great potential to improve the delivery of health education in Lesotho. Both groups suggested modifications, such as using the local language and adapting Nthabi for use by boys and young men.

Conclusions

Clinically tailored, culturally sensitive, and trustworthy content provided by Nthabi has the potential to improve accessibility of sexual and reproductive health information to young women in the low-middle-income country of Lesotho.

Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis

PURPOSE

Most individuals with a hereditary cancer syndrome are unaware of their genetic status to underutilization of hereditary cancer risk assessment. Chatbots, or programs that use artificial intelligence to simulate conversation, have emerged as a promising tool in health care and, more recently, as a potential tool for genetic cancer risk assessment and counseling. Here, we evaluated the existing literature on the use of chatbots in genetic cancer risk assessment and counseling.

METHODS

A systematic review was conducted using key electronic databases to identify studies which use chatbots for genetic cancer risk assessment and counseling. Eligible studies were further subjected to meta-analysis.

RESULTS

Seven studies met inclusion criteria, evaluating five distinct chatbots. Three studies evaluated a chatbot that could perform genetic cancer risk assessment, one study evaluated a chatbot that offered patient counseling, and three studies included both functions. The pooled estimated completion rate for the genetic cancer risk assessment was 36.7% (95% CI, 14.8 to 65.9). Two studies included comprehensive patient characteristics, and none involved a comparison group. Chatbots varied as to the involvement of a health care provider in the process of risk assessment and counseling.

CONCLUSION

Chatbots have been used to streamline genetic cancer risk assessment and counseling and hold promise for reducing barriers to genetic services. Data regarding user and nonuser characteristics are lacking, as are data regarding comparative effectiveness to usual care. Future research may consider the impact of chatbots on equitable access to genetic services.

A Survey of Conversational Agents and Their Applications for Self-Management of Chronic Conditions

Conversational agents have gained their ground in our daily life and various domains including healthcare. Chronic condition self-management is one of the promising healthcare areas in which conversational agents demonstrate significant potential to contribute to alleviating healthcare burdens from chronic conditions. This survey paper introduces and outlines types of conversational agents, their generic architecture and workflow, the implemented technologies, and their application to chronic condition self-management.

The Chatbots Are Invading Us: A Map Point on the Evolution, Applications, Opportunities, and Emerging Problems in the Health Domain

The inclusion of chatbots is potentially disruptive in society, introducing opportunities, but also important implications that need to be addressed on different domains. The aim of this study is to examine chatbots in-depth, by mapping out their technological evolution, current usage, and potential applications, opportunities, and emerging problems within the health domain. The study examined three points of view. The first point of view traces the technological evolution of chatbots. The second point of view reports the fields of application of the chatbots, giving space to the expectations of use and the expected benefits from a cross-domain point of view, also affecting the health domain. The third and main point of view is that of the analysis of the state of use of chatbots in the health domain based on the scientific literature represented by systematic reviews. The overview identified the topics of greatest interest with the opportunities. The analysis revealed the need for initiatives that simultaneously evaluate multiple domains all together in a synergistic way. Concerted efforts to achieve this are recommended. It is also believed to monitor both the process of osmosis between other sectors and the health domain, as well as the chatbots that can create psychological and behavioural problems with an impact on the health domain.

Applications of Artificial Intelligence to Obesity Research: Scoping Review of Methodologies

BACKGROUND

Obesity is a leading cause of preventable death worldwide. Artificial intelligence (AI), characterized by machine learning (ML) and deep learning (DL), has become an indispensable tool in obesity research.

OBJECTIVE

This scoping review aimed to provide researchers and practitioners with an overview of the AI applications to obesity research, familiarize them with popular ML and DL models, and facilitate the adoption of AI applications.

METHODS

We conducted a scoping review in PubMed and Web of Science on the applications of AI to measure, predict, and treat obesity. We summarized and categorized the AI methodologies used in the hope of identifying synergies, patterns, and trends to inform future investigations. We also provided a high-level, beginner-friendly introduction to the core methodologies to facilitate the dissemination and adoption of various AI techniques.

RESULTS

We identified 46 studies that used diverse ML and DL models to assess obesity-related outcomes. The studies found AI models helpful in detecting clinically meaningful patterns of obesity or relationships between specific covariates and weight outcomes. The majority (18/22, 82%) of the studies comparing AI models with conventional statistical approaches found that the AI models achieved higher prediction accuracy on test data. Some (5/46, 11%) of the studies comparing the performances of different AI models revealed mixed results, indicating the high contingency of model performance on the data set and task it was applied to. An accelerating trend of adopting state-of-the-art DL models over standard ML models was observed to address challenging computer vision and natural language processing tasks. We concisely introduced the popular ML and DL models and summarized their specific applications in the studies included in the review.

CONCLUSIONS

This study reviewed AI-related methodologies adopted in the obesity literature, particularly ML and DL models applied to tabular, image, and text data. The review also discussed emerging trends such as multimodal or multitask AI models, synthetic data generation, and human-in-the-loop that may witness increasing applications in obesity research.

Characterization of the Workspace and Limits of Operation of Laser Treatments for Vascular Lesions of the Lower Limbs

The increase of the aging population brings numerous challenges to health and aesthetic segments. Here, the use of laser therapy for dermatology is expected to increase since it allows for non-invasive and infection-free treatments. However, existing laser devices require doctors' manually handling and visually inspecting the skin. As such, the treatment outcome is dependent on the user's expertise, which frequently results in ineffective treatments and side effects. This study aims to determine the workspace and limits of operation of laser treatments for vascular lesions of the lower limbs. The results of this study can be used to develop a robotic-guided technology to help address the aforementioned problems. Specifically, workspace and limits of operation were studied in eight vascular laser treatments. For it, an electromagnetic tracking system was used to collect the real-time positioning of the laser during the treatments. The computed average workspace length, height, and width were 0.84 ± 0.15, 0.41 ± 0.06, and 0.78 ± 0.16 m, respectively. This corresponds to an average volume of treatment of 0.277 ± 0.093 m³. The average treatment time was 23.2 ± 10.2 min, with an average laser orientation of 40.6 ± 5.6 degrees. Additionally, the average velocities of 0.124 ± 0.103 m/s and 31.5 + 25.4 deg/s were measured. This knowledge characterizes the vascular laser treatment workspace and limits of operation, which may ease the understanding for future robotic system development.

Two new species of the genus Mecyclothorax Sharp from New Guinea (Coleoptera: Carabidae: Psydrinae)

Chronic diseases typically require long-term management through healthy lifestyle practices and pharmacological intervention. Although efficacious treatments exist, disease control is often sub-optimal leading to chronic disease-related sequela. Poor disease control can partially be explained by the ‘one size fits all’ pharmacological approach. Precision medicine aims to tailor treatments to the individual. CURATE.AI is a dosing optimisation platform that considers individual factors to improve the precision of drug therapies. CURATE.AI has been validated in other therapeutic areas, such as cancer, but has yet to be applied in chronic disease care. We will evaluate the CURATE.AI system through a single-arm feasibility study (n = 20 hypertensives and n = 20 type II diabetics). Dosing decisions will be based on CURATE.AI recommendations. We will prospectively collect clinical and qualitative data and report on the clinical effect, implementation challenges, and acceptability of using CURATE.AI. In addition, we will explore how to enhance the algorithm further using retrospective patient data. For example, the inclusion of other variables, the simultaneous optimisation of multiple drugs, and the incorporation of other artificial intelligence algorithms. Overall, this project aims to understand the feasibility of using CURATE.AI in clinical practice. Barriers and enablers to CURATE.AI will be identified to inform the system’s future development.